BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Letters

• Publication date

  2016-10-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2016.07.034PMID 27477900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New concepts on BARD1: Regulator of BRCA pathways and beyond.

  2016cited by this paper
• The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.

  2015cited by this paper
• Mitochondrial diseases: From the lab bench to therapies.

  2015cited by this paper
• MYCN and the epigenome

  2013cited by this paper
• HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b

  2013cited by this paper
• Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

  2012cited by this paper
• BARD1: An independent predictor of survival in non‐small cell lung cancer

  2012cited by this paper
• Cisplatin Induces Differentiation of Breast Cancer Cells

  2012cited by this paper
• The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations

  2012cited by this paper
• Leaf Morphology, Taxonomy and Geometric Morphometrics: A Simplified Protocol for Beginners

  2011cited by this paper
• Real-Time Monitoring of Cisplatin-Induced Cell Death

  2011cited by this paper
• Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

  2010cited by this paper
• Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.

  2009cited by this paper
• BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis*

  2007cited by this paper
• The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.

  2007cited by this paper
• Bax activation and mitochondrial insertion during apoptosis

  2007cited by this paper
• Identification of BARD1 splice-isoforms involved in human trophoblast invasion.

  2007cited by this paper
• Oncogenic BARD1 isoforms expressed in gynecological cancers.

  2007cited by this paper
• Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death

  2007cited by this paper
• A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.

  2006cited by this paper
• BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase

  2005cited by this paper
• Nuclear–cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1

  2004cited by this paper
• BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.

  2004cited by this paper
• Nuclear–cytoplasmic translocation of BARD1 is linked to its apoptotic activity

  2004cited by this paper
• Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

  2003cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

  1998cited by this paper

• BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

  2025cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target

  2020cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

  2019cites this paper
• Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis

  2018cites this paper
• Apoptosis and Caspase 3 Pathway Role on Anti-Proliferative Effects of Scrophulariaoxy Sepala Methanolic Extract on Caco-2 Cells

  2017cites this paper
• A light weight SNP detection algorithm for the breast cancer targeted sequencing data

  2017cites this paper